Appropriate cytotoxic pharmaceutical combination especially for the treatment of cancers

摘要

The invention relates to a cytotoxic pharmaceutical combination comprising: at least a first antibody possessing the capacity of selective recognition of a target antigen or antigens carried by cells to be destroyed, the said antibody being characteristic of an animal species different from that of the target cells, at least one cytotoxic conjugate obtained by covalent bond coupling of the A chain of ricin with a second antibody specific for immunoglobins of the animal species to which the said first antibody or antibodies belong.